Medline MDLN
NASDAQ MDLN
$34.38 -0.31 (-0.89%)
As of: Sep 9, 2026 · 11:33 AM EDT

Medline (MDLN) Price to Earnings (2026)

Medline's (MDLN) quarterly Price to Earnings came in at 367.65 in Q2 2026, up 61.68% quarter-over-quarter from 227.39 in Q1 2026.

Analysis

Medline (MDLN) Price to Earnings (2026) Analysis & Trends

Medline (MDLN) has reported Price to Earnings for 1 consecutive years, with 367.65 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Price to Earnings changed N/A year-over-year to 367.65 in Q2 2026; TTM through Jun 2026 was 49.47, a N/A change from a year earlier, with the FY2025 full-year figure at 47.7, changed N/A from the prior year.
  • Price to Earnings was 367.65 for Q2 2026 at Medline, up from 227.39 in the prior quarter.
  • Over five years, Price to Earnings peaked at 367.65 in Q2 2026 and troughed at 227.39 in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Becton Dickinson 49.56 Bn 48.70 Bn 2.32 Bn
2 Medline 29.46 Bn 26.79 Bn 2.22 Bn
3 West Pharmaceutical Services 23.96 Bn 23.52 Bn 329.20 Mn
4 Baxter International 12.87 Bn 10.72 Bn 1.03 Bn
5 Stevanato Group S.p.A 5.60 Bn 5.49 Bn 100.91 Mn
6 Acme United 232.75 Mn 227.71 Mn 26.69 Mn
7 Rockwell Medical 32.38 Mn 7.58 Mn 3.24 Mn
8 Retractable Technologies 20.96 Mn -18.91 Mn 190,852.00
9 United Health Products 8.37 Mn 8.34 Mn -
10 Cuprina Holdings (Cayman) 7.55 Mn 4.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 367.65
Mar 28, 2026 227.39